doi: 10.1016/0006-2952(72)90164-5.
Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum
- PMID: 4645883
- DOI: 10.1016/0006-2952(72)90164-5
Item in Clipboard
Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum
Biochem Pharmacol.
.
No abstract available
Similar articles
-
Effect of gamma-hydroxybutyrate and gamma-butyrolactone on dopamine synthesis and uptake by rat striatum.Biochem Pharmacol. 1972 Oct 1;21(19):2649-52. doi: 10.1016/0006-2952(72)90233-x. Biochem Pharmacol. 1972. PMID: 4661622 No abstract available.
-
Release of monoamines from the striatum and hypothalamus: effect of -hydroxybutyrate.Br J Pharmacol. 1972 Sep;46(1):101-15. doi: 10.1111/j.1476-5381.1972.tb06853.x. Br J Pharmacol. 1972. PMID: 5084815 Free PMC article.
-
Effect of anesthetic doses of hydroxybutyrate on subcortical concentrations of homovanillic acid.Eur J Pharmacol. 1971 Jun;15(1):52-9. doi: 10.1016/0014-2999(71)90078-1. Eur J Pharmacol. 1971. PMID: 5161341 No abstract available.
-
Drugs affecting monoamines in the basal ganglia.Adv Biochem Psychopharmacol. 1972;6:135-48. Adv Biochem Psychopharmacol. 1972. PMID: 4560163 Review. No abstract available.
-
[The role of dopamine in the physiology and pathology of the basal ganglia].Zh Nevropatol Psikhiatr Im S S Korsakova. 1972;72(4):595-603. Zh Nevropatol Psikhiatr Im S S Korsakova. 1972. PMID: 4341763 Review. Russian. No abstract available.
Cited by
-
Dopaminergic neurons: reversal of effects elicited by gamma-butyrolactone by stimulation of the nigro-neostriatal pathway.Naunyn Schmiedebergs Arch Pharmacol. 1976 Oct;295(1):15-20. doi: 10.1007/BF00509766. Naunyn Schmiedebergs Arch Pharmacol. 1976. PMID: 12482
-
Alterations in cerebrospinal fluid dopamine metabolites following physostigmine infusion.Psychopharmacology (Berl). 1981;72(2):155-60. doi: 10.1007/BF00431649. Psychopharmacology (Berl). 1981. PMID: 6782605 Clinical Trial.
-
Role of dopamine storage function in the control of rat striatal tyrosine hydroxylase activity.Naunyn Schmiedebergs Arch Pharmacol. 1980 Aug;313(1):39-44. doi: 10.1007/BF00505803. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 6111026
-
Decreased 3H-L-quinuclidinyl benzilate binding and muscarine receptor subsensitivity after chronic gamma-butyrolactone treatment.Naunyn Schmiedebergs Arch Pharmacol. 1981 Dec;318(1):14-8. doi: 10.1007/BF00503306. Naunyn Schmiedebergs Arch Pharmacol. 1981. PMID: 7329448
-
Chronic gamma-butyrolactone (GBL) treatment: a potential model of dopamine hypoactivity.Naunyn Schmiedebergs Arch Pharmacol. 1979 Nov;309(3):247-54. doi: 10.1007/BF00504757. Naunyn Schmiedebergs Arch Pharmacol. 1979. PMID: 43476 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
